Honokiol-Chlorambucil Co-Prodrugs Selectively Enhance the Killing Effect through STAT3 Binding on Lymphocytic Leukemia Cells In Vitro and In Vivo
Li Xia,
Dali Kang,
Dan Wan,
Chu Chu,
Meizi Chen,
Shuihan Zhang,
Xiong Li,
Leye He,
Jianye Yan,
Teng Liu,
Yongbo Peng
Affiliations
Li Xia
School of Traditional Chinese Medicine, Guangdong Food and Drug Vocational College, Guangzhou, PR China
Dali Kang
School of Traditional Chinese Medicine, Guangdong Food and Drug Vocational College, Guangzhou, PR China
Dan Wan
Institute of Chinese Medicine, Hunan Academy of Traditional Chinese Medicine&Innovation Centre for Science and Technology, Hunan University of Chinese Medicine, Changsha, PR China
Chu Chu
College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, PR China
Meizi Chen
Department of General Internal Medicine, The First People’s Hospital of Chenzhou, Chenzhou, PR China
Shuihan Zhang
Institute of Chinese Medicine, Hunan Academy of Traditional Chinese Medicine&Innovation Centre for Science and Technology, Hunan University of Chinese Medicine, Changsha, PR China
Xiong Li
Institute of Chinese Medicine, Hunan Academy of Traditional Chinese Medicine&Innovation Centre for Science and Technology, Hunan University of Chinese Medicine, Changsha, PR China
Leye He
Department of Urological Surgery and Research Institute for Prostate Disease, Third Xiangya Hospital, Central South University, Changsha, PR China
Jianye Yan
Institute of Chinese Medicine, Hunan Academy of Traditional Chinese Medicine&Innovation Centre for Science and Technology, Hunan University of Chinese Medicine, Changsha, PR China
Teng Liu
Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, PR China
Yongbo Peng
Institute of Chinese Medicine, Hunan Academy of Traditional Chinese Medicine&Innovation Centre for Science and Technology, Hunan University of Chinese Medicine, Changsha, PR China
